Y Xu, H Du, Y Chen, C Ma, Q Zhang, H Li… - Critical Reviews in …, 2023 - Taylor & Francis
Despite ongoing breakthroughs in novel anticancer therapies, chemotherapy remains a
mainstream therapeutic modality in different types of cancer. Unfortunately, chemotherapy …